SCHEMBL4763102

SCHEMBL4763102

C=S1(=O)CCN(CC(C)(C)C)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL102281 0.82 KMT2A (0.41)
SCHEMBL17718799 0.75 KMT2A (0.37)
SCHEMBL13086714 0.75 SMN1; SMN2 (0.34)
SCHEMBL19543019 0.72 HTR7 (0.34)
SCHEMBL11840677 0.72
SCHEMBL12092353 0.72 HTR7 (0.34)
SCHEMBL19543661 0.72 HTR7 (0.34)
SCHEMBL2721284 0.70
SCHEMBL736240 0.69 HTT (0.41)
SCHEMBL29393426 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170239190-A1 MODIFIED ALGINATES FOR CELL ENCAPSULATION AND CELL THERAPY THE CHILDREN'S MEDICAL CENTER CORPORATION 2017-08-24 US disclosed
US-9493412-B2 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2016-11-15 US disclosed
US-9458463-B2 Method for treatment of diabetes by a small molecule inhibitor for GRK5 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2016-10-04 US disclosed
US-20140228321-A1 PYRROLINONE CARBOXAMIDE COMPOUNDS USEFUL AS ENDOTHELIAL LIPASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2014-08-14 US disclosed
US-20120122840-A1 COMPOUNDS AND THERAPEUTIC USES THEREOF MYREXIS, INC. (US) 2012-05-17 US disclosed